pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,933 catalysts · 5,063 phase readout · 2,308 8k filing · 310 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa310
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Week of Jul 27, 2026

    16
    ›Jul 28, 20268k filing1d ago$INFU — InfuSystem Holdings, Inc (INFU) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$VXRT — Vaxart, Inc. (VXRT) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$TTRX — Turn Therapeutics Inc. (TTRX) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$BCAX — Bicara Therapeutics Inc. (BCAX) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$RLMD — RELMADA THERAPEUTICS, INC. (RLMD) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$LAB — STANDARD BIOTOOLS INC. (LAB) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$PHGE — BiomX Inc. (PHGE) — 8-K filing

    Items: 1.01, 3.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$AMIX — Autonomix Medical, Inc. (AMIX) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$NRC — NRC HEALTH (NRC) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d agoEntera Bio Ltd. (ENTX, ENTXW) — 8-K filing

    Items: 1.01, 3.02, 5.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$PAHC — PHIBRO ANIMAL HEALTH CORP (PAHC) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$TPST — Tempest Therapeutics, Inc. (TPST) — 8-K filing

    Items: 5.07, 8.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$NPCE — NeuroPace Inc (NPCE) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$VYNE — Yarrow Bioscience, Inc. (VYNE) — 8-K filing

    Items: 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$HAE — HAEMONETICS CORP (HAE) — 8-K filing

    Items: 5.02, 5.07, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$JUNS — JUPITER NEUROSCIENCES, INC. (JUNS) — 8-K filing

    Items: 3.02, 8.01, 9.01

    full page →edgar 8k ↗

    Week of Jan 4, 2027

    1
    ›Jan 4, 2027pdufa159dPDUFA — 2027-01-04

    action date of January 4, 2027

    full page →pdufa extract ↗

    Week of Jan 18, 2027

    1
    ›Jan 21, 2027pdufa176dPDUFA — 2027-01-21

    action date of Jan. 21, 2027

    full page →pdufa extract ↗

    Date TBD

    32
    ›TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›TBDapproval
    ← prev
    page 58 of 159
    next →
    TRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

    Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

    Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Definium Therapeutics, Inc.

    Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06466434: Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06806709: Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

    Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07178509: A Study of SCAD Using Stress Contrast EchocardiographyMayo Clinic

    Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07403409: Scapular Repeated Contractions Facilitation Versus Hold-relax Techniques in Patients With Adhesive Capsulitis

    Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06721663: Multisensory Environment Stimulation Therapy on Postural Control in Cerebral Palsy

    Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06624787: Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

    Sponsor: Liverpool School of Tropical Medicine. Phase: NA. Conditions: Crimean-Congo Haemorrhagic Fever

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07527221: Safety and Tolerability of ZE74-0282 in Healthy VolunteersCerta Therapeutics Pty Ltd

    Sponsor: Eilean Therapeutics AU Pty Ltd. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07329114: Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)

    Sponsor: Chandan Sen. Phase: NA. Conditions: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01778504: Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Neuropsychiatric Disorder, Neurological Disorder, Neurodevelopmental Disorder, Sleep

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05103033: Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)University of Washington

    Sponsor: University of Washington. Phase: NA. Conditions: Mental Health Disorder

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06906952: A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer

    Sponsor: Nanchang University. Phase: NA. Conditions: Natural Orifice Specimen Extraction Surgery, Robotic Surgery, Short-term Outcomes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07281547: Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and PainMayo Clinic

    Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Endometrial Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07442149: An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005ALUMIS INC.

    Sponsor: Alumis Inc. Phase: PHASE1. Conditions: Healthy Volunteer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07418138: Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

    Sponsor: Hu Liangshuo. Phase: . Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC), Tyrosine Kinase Inhibitor, Survival Rate

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07362238: Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Immune Thrombocytopenia, Treatment

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04221438: Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node InvolvementArray BioPharma Inc

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Recurrent Cutaneous Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04461158: CCCR Lupus Patient Navigator Program

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Systemic Lupus Erythematosus (SLE)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07307248: To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

    Sponsor: Asian Institute of Gastroenterology, India. Phase: NA. Conditions: Walled Off Necrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06877026: FibroScan-Reproducibility and Repeatability Study

    Sponsor: Echosens. Phase: NA. Conditions: Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07418385: Voluntary HIV Screening in the General Population in France

    Sponsor: Université de Reims Champagne-Ardenne. Phase: . Conditions: Human Immunodeficiency Virus (HIV)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03078543: Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee SystemSMITH & NEPHEW PLC

    Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthroplasty, Replacement, Knee

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07480343: 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

    Sponsor: Iantrek, Inc.. Phase: . Conditions: Open-angle Glaucoma (OAG)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07550543: PEMF Therapy in Shoulder Tendinopathy

    Sponsor: Balnear and Rehabilitation Sanatorium Techirghiol. Phase: NA. Conditions: Shoulder Tendinopathy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07298408: Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot StudyJazz Pharmaceuticals plc

    Sponsor: Florida A&M University. Phase: PHASE1. Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07422025: Prognostic Value of Preoperative Frailty Assessment in Geriatric Lower Limb Orthopedic Surgery

    Sponsor: Benha University. Phase: . Conditions: Lower Limb Fracture

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07414576: AI-driven Total Parenteral Nutrition Platform

    Sponsor: Takeoff41, Inc.. Phase: NA. Conditions: Intestinal Failure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05003817: Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular UnloadingGuy's and St Thomas' NHS Foundation Trust

    Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: PHASE3. Conditions: Ischemic Heart Disease, Coronary Artery Disease

    full page →ctgov ↗
    $ABBV263.20+2.45%
    $NVS159.85+2.40%
    $SNN30.25+5.29%
    $JAZZ256.92+0.58%
    $DFTX
    $ALMS27.03-0.18%